Skip to main content

Table 6 Unique differences in metabolic pathways information of the compounding agent

From: Synergistic mechanism of Bacillus subtilis Czk1 combined with propiconazole and tebuconazole mixtures against Pyrrhoderma noxium

Pathway

ko_ID

Unique compound

Compound

Rich factor

P-value

Alpha-Linolenic acid metabolism

ko00592

12

20

0.6

0.028365

Valine, leucine and isoleucine degradation

ko00280

4

5

0.8

0.038597

Benzoate degradation

ko00362

4

4

1

0.010281